| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5627454 | Clinical Neurophysiology | 2017 | 7 Pages |
Abstract
Fampridine may improve walking distance in MS. Nerve excitability assessment may assist in identifying those patients most likely to respond to fampridine.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Hannah Pickering, Jenna Murray, Cindy S.-Y. Lin, Christine Cormack, Andrew Martin, Matthew C. Kiernan, Arun V. Krishnan,